IMMUNOPAK Trademark

Trademark Overview

On Wednesday, April 29, 2020, a trademark application was filed for IMMUNOPAK with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPAK trademark a serial number of 88893297. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, April 4, 2025. This trademark is owned by The Prolmmune Company, L.L.C.. The IMMUNOPAK trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for medical purpose; Amino acids for medical purposes for physiological synthesis of glutathione and the reduction of oxidative stress; Antivirals; Antivirals for physiological synthesis of glutathione and the reduction of oxidative stress; Pharmaceutical preparations, namely, antivirals; all the foregoing for human use
immunopak

General Information

Serial Number88893297
Word MarkIMMUNOPAK
Filing DateWednesday, April 29, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, April 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesAmino acids for medical purpose; Amino acids for medical purposes for physiological synthesis of glutathione and the reduction of oxidative stress; Antivirals; Antivirals for physiological synthesis of glutathione and the reduction of oxidative stress; Pharmaceutical preparations, namely, antivirals; all the foregoing for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThe Prolmmune Company, L.L.C.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRhinebeck, NY 12572
Party NameThe Prolmmune Company, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRhinebeck, NY 12572

Trademark Events

Event DateEvent Description
Wednesday, July 29, 2020NON-FINAL ACTION E-MAILED
Saturday, May 2, 2020NEW APPLICATION ENTERED
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 8, 2021NON-FINAL ACTION WRITTEN
Monday, March 8, 2021NON-FINAL ACTION E-MAILED
Monday, March 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 18, 2021NON-FINAL ACTION WRITTEN
Monday, October 18, 2021NON-FINAL ACTION E-MAILED
Monday, October 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Monday, June 13, 2022FINAL REFUSAL WRITTEN
Monday, June 13, 2022FINAL REFUSAL E-MAILED
Monday, June 13, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 13, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, December 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2023SOU EXTENSION 1 GRANTED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 4, 2023SOU EXTENSION 1 FILED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 4, 2025SOU TEAS EXTENSION RECEIVED
Friday, October 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 3 GRANTED
Friday, October 4, 2024SOU EXTENSION 3 FILED
Friday, April 4, 2025SOU EXTENSION 4 FILED
Friday, October 3, 2025SOU TEAS EXTENSION RECEIVED
Friday, April 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 4, 2025SOU EXTENSION 4 GRANTED

Related Keywords

immunopak antivirals glutathione amino stress synthesis oxidative reduction physiological medical acids